While early evidence suggested amplification of TOP2A is associated with overexpression of the protein125, differentiating overexpression from normal expression in tumor samples has been challenging and demonstrating a correlation between amplification and expression has not yielded consistent results. Here, TOP2A is linked to neoplasm.